Literature DB >> 7728032

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study.

A Ott1, M M Breteler, F van Harskamp, J J Claus, T J van der Cammen, D E Grobbee, A Hofman.   

Abstract

OBJECTIVE: To estimate the prevalence of dementia and its subtypes in the general population and examine the relation of the disease to education.
DESIGN: Population based cross sectional study.
SETTING: Ommoord, a suburb of Rotterdam.
SUBJECTS: 7528 participants of the Rotterdam study aged 55-106 years.
RESULTS: 474 cases of dementia were detected, giving an overall prevalence of 6.3%. Prevalence ranged from 0.4% (5/1181 subjects) at age 55-59 years to 43.2% (19/44) at 95 years and over. Alzheimer's disease was the main subdiagnosis (339 cases; 72%); it was also the main cause of the pronounced increase in dementia with age. The relative proportion of vascular dementia (76 cases; 16%), Parkinson's disease dementia (30; 6%), and other dementias (24; 5%) decreased with age. A substantially higher prevalence of dementia was found in subjects with a low level of education. The association with education was not due to confounding by cardiovascular disease.
CONCLUSIONS: The prevalence of dementia increases exponentially with age. About one third of the population aged 85 and over has dementia. Three quarters of all dementia is due to Alzheimer's disease. In this study an inverse dose-response relation was found between education and dementia--in particular, Alzheimer's disease.

Entities:  

Mesh:

Year:  1995        PMID: 7728032      PMCID: PMC2549358          DOI: 10.1136/bmj.310.6985.970

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability.

Authors:  J R Copeland; M J Kelleher; J M Kellett; A J Gourlay; B J Gurland; J L Fleiss; L Sharpe
Journal:  Psychol Med       Date:  1976-08       Impact factor: 7.723

Review 3.  Education and the prevalence of dementia and Alzheimer's disease.

Authors:  R Katzman
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

4.  Epidemiology, education, and the ecology of Alzheimer's disease.

Authors:  R P Friedland
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

5.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

6.  Apolipoprotein E polymorphism and Alzheimer's disease.

Authors:  J Poirier; J Davignon; D Bouthillier; S Kogan; P Bertrand; S Gauthier
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study.

Authors:  M M Breteler; J J Claus; D E Grobbee; A Hofman
Journal:  BMJ       Date:  1994-06-18

10.  Multi-infarct dementia.

Authors:  V Hachinski
Journal:  Neurol Clin       Date:  1983-02       Impact factor: 3.806

View more
  147 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.

Authors:  N Bhana; C M Spencer
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 4.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

5.  Cognitive function in the Caerphilly study: associations with age social class, education and mood.

Authors:  J E Gallacher; P C Elwood; C Hopkinson; P M Rabbitt; B T Stollery; P M Sweetnam; C Brayne; F A Huppert
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

6.  Understanding dementia prevalence among centenarians.

Authors:  Leonard W Poon; John L Woodard; L Stephen Miller; Robert Green; Marla Gearing; Adam Davey; Jonathan Arnold; Peter Martin; Ilene C Siegler; Lusine Nahapetyan; Young Sek Kim; William Markesbery
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

7.  Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Authors:  Edeltraut Kröger; Rob van Marum; Patrick Souverein; Toine Egberts
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

8.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

9.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

10.  [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

Authors:  T Möller; C Born; M F Reiser; H-J Möller; H Hampel; S J Teipel
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.